The Rising Prevalence of Gallstones and High Consumption of Alcohol is Expected to Propel the Growth of Acute Pancreatitis Market by CAGR of 5.91%

Pune, India, December 2019, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Acute Pancreatitis Market.

Market Highlights

Acute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period.

Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually.

There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market.

Segment Analysis

The Global Acute Pancreatitis Market has been segmented into Cause, Treatment & Diagnosis, and End User.

Based on the cause, the global acute pancreatitis market has been segmented into gallstones, alcohol, and others. The gallstones segment accounted for the largest market share of 49.52% in 2018 and is expected to exhibit a CAGR of 5.88% by the end of the forecast period.  Rising cases of gall stones worldwide and growing older population along with hereditary predispositions are major risk factors causing gall stones, which is driving the growth of the acute pancreatitis market. For instance, according to the World Gastroenterology Organization, about 20 million people in the USA (15% of the population) had gallstones in 2016.

On the basis of treatment & diagnosis, the global acute pancreatitis market has been segregated into treatment and diagnosis. The treatment segment is further classified as intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ERCP), and others. The diagnosis segment is further classified as imaging tests and laboratory tests.

On the basis of end-user, the global acute pancreatitis market has been segmented into hospitals & clinics and others.

Regional Analysis

The Global Acute Pancreatitis Market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The increasing prevalence of gall stones and alcohol consumption among the population and the availability of advanced healthcare facilities in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. Additionally, the rising geriatric population increases the rate of prevalence of gallstones as they are more susceptible to diseases. The increasing incidence of acute pancreatitis has led to a rise in the demand for advanced and effective diagnostic tests and treatment options.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565

Market Players

Market Research Future (MRFR) recognizes CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co., Baxter International Inc., B. Braun Melsungen AG, General Electric Company, Medtronic, Boston Scientific Corporation, and Fresenius Kabi USA as the key players in the Global Acute Pancreatitis Market.

Key Findings of the Study:

• The Global Acute Pancreatitis Market is projected to reach over USD 7372.01 Million by 2025 at a 91% CAGR during the review period of 2019 to 2025.

• Americas accounted for the largest market share with the US being the major contributor to the growth of the market.

• By cause, the gallstones segment is projected to register the largest market share of 49.52% during the forecast period. According to a recent research study by the Dutch Pancreatitis Study Group, the most common cause of acute pancreatitis in Europe and North America is gall bladder.   

• Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.